DE BERNARDI ELISABETTA

Cerina, V., Rui, C., DE BERNARDI, E., Moresco, R., Giussani, C., Basso, G., et al. (2024). Preliminary assessment of semiautomated segmentation tool for GBM neurosurgery: a BraTS-Toolkit approach. Intervento presentato a: 19th European Molecular Imaging Meeting - EMIM (European Society of Molecular Imaging - ESMI) - 12-15 March, Porto, Portugal. Detail

Maino, C., Vernuccio, F., Cannella, R., Franco, P., Giannini, V., Dezio, M., et al. (2024). Radiomics and liver: Where we are and where we are headed?. EUROPEAN JOURNAL OF RADIOLOGY, 171(February 2024) [10.1016/j.ejrad.2024.111297]. Detail

Cerina, V., Crivellaro, C., Morzenti, S., Pozzi, F., Bigiogera, V., Jonghi-Lavarini, L., et al. (2024). A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line. HELIYON, 10(1) [10.1016/j.heliyon.2023.e23340]. Detail

Meazza Prina, M., Gotuzzo, I., Cazzaniga, M., De Bernardi, E., Cafaro, P., Capici, S., et al. (2023). Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study. Intervento presentato a: SABCS - San Antonio Breast Cancer Symposium - DEC 06-10, 2022, San Antonio, Texas, USA [10.1158/1538-7445.SABCS22-P6-01-42]. Detail

Bonaffini, P., De Bernardi, E., Corsi, A., Franco, P., Nicoletta, D., Muglia, R., et al. (2023). Towards the Definition of Radiomic Features and Clinical Indices to Enhance the Diagnosis of Clinically Significant Cancers in PI-RADS 4 and 5 Lesions. CANCERS, 15(20) [10.3390/cancers15204963]. Detail